I-Mab ADR (NASDAQ: IMAB) established initial surge of 16.02% at $5.07, as the Stock market unbolted on Wednesday, before settling in for the price of $4.37 at the close. Taking a more long-term approach, IMAB posted a 52-week range of $0.60-$5.90.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 28.35%. Meanwhile, its Annual Earning per share during the time was 28.35%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -59.72%. This publicly-traded company’s shares outstanding now amounts to $81.79 million, simultaneously with a float of $63.68 million. The organization now has a market capitalization sitting at $401.49 million. At the time of writing, stock’s 50-day Moving Average stood at $4.02, while the 200-day Moving Average is $1.96.
I-Mab ADR (IMAB) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the I-Mab ADR industry. I-Mab ADR’s current insider ownership accounts for 19.59%, in contrast to 12.32% institutional ownership.
I-Mab ADR (IMAB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
I-Mab ADR’s EPS decrease for this current 12-month fiscal period is -59.72% and is forecasted to reach -0.20 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -28.40% through the next 5 years, which can be compared against the 28.35% growth it accomplished over the previous five years trading on the market.
I-Mab ADR (NASDAQ: IMAB) Trading Performance Indicators
Let’s observe the current performance indicators for I-Mab ADR (IMAB). It’s Quick Ratio in the last reported quarter now stands at 22.82.
In the same vein, IMAB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.71, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.20 at the market close of one year from today.
Technical Analysis of I-Mab ADR (IMAB)
Now, what If we examine the latest scores posted by [I-Mab ADR, IMAB]. During the last 5-days, its volume was better the volume of 1.07 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 83.55% While, its Average True Range was 79.02.
Raw Stochastic average of I-Mab ADR (IMAB) in the period of the previous 100 days is set at 83.54%, which indicates a major rise in contrast to 77.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.36 that was lower than 0.37 volatility it exhibited in the past 100-days period.